Monthly Archives: March 2010

Reps Allowed Access; Just Make an Appointment

By George Koroneos | Published: March 17, 2010

Image by Joseph Cote via Flickr SK&A released the results of its latest physician survey, and it turns out that most docs are happy to meet with sales reps as long as they make an appointment in advance. In fact, 98 percent of offices that allow sales reps to make office calls see 20 reps per week. “That’s [...]

Posted in Sales | Tagged Diabetes mellitus, Health, Health care system, Marketing, Medical imaging, Medicine, Pathology, Physician, Sales Management, Sales Reps | 1 Comment

Upcoming Webcast: The Visibility Solution

By George Koroneos | Published: March 15, 2010

The Visibility Solution: Delivering an Accurate View of Clinical Operations Thursday, April 1, 2010 at 11:00 AM PT; 2:00 PM ET; 16:00 GMT This event focuses on our Clinical Trials solution with HighPoint Solutions and is designed to illustrate how pharma companies can reduce the risk and expense of the clinical trial process with better use of [...]

Posted in Webcast | Tagged Biotechnology and Pharmaceuticals, business, Clinical trial, Contract Research Organizations, Kalido, Pharmaceutical drug, Pharmaceuticals, Products Evaluation | Leave a comment

Is There Life After Big Pharma?

By Julian Upton | Published: March 11, 2010

Guest blog by Pharm Exec Europe’s Jacky Law. It’s hard to get precise figures of how many people have been taken off the payroll at pharma and biotech companies recently. According to staffing firm, Challender, Gray and Christmas, the combined industries shed 58,969 jobs in the first nine months of 2009, 15,000 more than the whole [...]

Posted in Corporate Responsibility, Deals, Europe, Global, Guest Blog | Tagged Big Pharma, downturn, in-licensing, Medivation, pharma. layoffs, redundancies | Leave a comment

PhRMA Calls for New Style Search Link Ads

By George Koroneos | Published: March 10, 2010

The Pharmaceutical Research and Manufacturers of America (PhRMA), on Tuesday, revealed its comments to FDA about how to handle search link ads on sites such as Google and Yahoo. PhRMA showed off two versions of its recommended search ad, one with a universal symbol that’s easily recognizable as a link to risk information (the sample one [...]

Posted in E-Media, Marketing | Tagged ads, Google, Marketing, online, PhRMA, social media | Leave a comment

Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant

By Oriana Schwindt | Published: March 5, 2010

Takeda’s US subsidiary launched its proton pump inhibitor dexlansoprazole last February under the name Kapidex. No one thought they’d have to find a new name a year later. But shortly after the launch, the company began getting reports of dispensing errors. Some were due to prescription misreading, others to simple, honest mistakes. The two drugs causing [...]

Posted in Corporate Responsibility, FDA, Marketing, News, Safety, Strategy | Tagged Casodex, chronic pain, Dexilant, dexlansoprazole, dispensing error, FDA, Kadian, Kapidex, Prostate cancer, proton pump inhibitor, Takeda | 2 Comments